Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Hodgkin's Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00770224
What this trial is testing

S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 87
Testing effectiveness (Phase 2)Study completedNCT00062296
What this trial is testing

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Fox Chase Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00003784
What this trial is testing

S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 102
Not applicableStudy completedNCT02037256
What this trial is testing

Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+86 more
Barbara Ann Karmanos Cancer Institute 23
Large-scale testing (Phase 3)Study completedNCT00312845
What this trial is testing

Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Millennium Pharmaceuticals, Inc. 676
Testing effectiveness (Phase 2)Active Not RecruitingNCT05950165
What this trial is testing

Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Cho Pharma Inc. 37
Not applicableStudy completedNCT00098566
What this trial is testing

Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaQuality of Life
Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Large-scale testing (Phase 3)Ended earlyNCT00057343
What this trial is testing

Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 400
Large-scale testing (Phase 3)Study completedNCT00168740
What this trial is testing

Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)

Who this might be right for
Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
Biogen 150
Testing effectiveness (Phase 2)Study completedNCT00003210
What this trial is testing

Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+14 more
National Cancer Institute (NCI) 105
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07713459
What this trial is testing

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Who this might be right for
Lymphoma NonhodgkinMarginal Zone B Cell LymphomaDiffuse Large B Cell Lymphoma (DLBCL)+2 more
Kure Cells, INC 105
Early research (Phase 1)Ended earlyNCT05169489
What this trial is testing

BbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Regeneron Pharmaceuticals 15
Testing effectiveness (Phase 2)Study completedNCT00002982
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00294632
What this trial is testing

Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00004916
What this trial is testing

Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Large-scale testing (Phase 3)Ended earlyNCT00004874
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 31
Testing effectiveness (Phase 2)Study completedNCT00138164
What this trial is testing

Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 50
Post-approval studies (Phase 4)Study completedNCT00430352
What this trial is testing

MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 545
Testing effectiveness (Phase 2)Study completedNCT00048555
What this trial is testing

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 90
Next Page